Plexus Corporation
PLXS
$250.03
-3.41%
Plexus Corporation is a global provider of comprehensive product lifecycle solutions, specializing in the design, manufacturing, and servicing of complex electronic products for demanding regulatory environments. The company operates as a key partner for market leaders and disruptive innovators across critical sectors including Healthcare/Life Sciences, Aerospace/Defense, and Industrial, distinguishing itself through deep engineering expertise and a vertically integrated supply chain model. The current investor narrative is driven by strong execution and robust demand in its core end-markets, particularly in medical devices and semiconductor capital equipment, as evidenced by recent quarterly revenue growth and a significant stock price appreciation over the past year, suggesting the market is rewarding its operational momentum and strategic positioning.…
PLXS
Plexus Corporation
$250.03
PLXS 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Plexus Corporation's 12-month outlook, with a consensus price target around $325.04 and implied upside of +30.0% versus the current price.
Average Target
$325.04
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$200 - $325
Analyst target range
Analyst coverage appears limited with only one analyst providing estimates in the dataset, though institutional ratings show activity from several firms including Benchmark, Needham, and Stifel. The consensus sentiment among the rating actions is bullish, with recent actions from Benchmark and Needham maintaining 'Buy' ratings, while Stifel maintains a 'Hold'; the average target price or a clear consensus recommendation cannot be derived from the provided data, implying insufficient information to calculate a precise upside/downside implication. The wide range in estimated EPS for the forward period, from a low of $9.56 to a high of $10.16, and the presence of both Buy and Hold ratings, signals there is some divergence in analyst views, which is typical and reflects debates over the sustainability of the current growth cycle and margin profile; the limited explicit target data suggests investors should seek more comprehensive coverage for clearer directional signals.
Bulls vs Bears: PLXS Investment Factors
The evidence currently favors the bull case, grounded in powerful fundamental momentum, a fortress balance sheet, and a valuation that, while elevated, is not at historical extremes. However, the bear points highlight significant near-term risks, primarily the stock's extreme technical overextension after a near-100% run. The single most important tension in the investment debate is whether PLXS's accelerating revenue growth (9.6% YoY) can justify and sustain its forward-looking valuation premium (27.43x forward P/E) in the face of inherently thin operating margins. The resolution of this growth-versus-margin dynamic will determine if the stock consolidates gains or faces a painful de-rating.
Bullish
- Explosive Revenue Growth & Momentum: PLXS has delivered 94.75% stock price appreciation over the past year, driven by accelerating quarterly revenue growth, which reached 9.6% YoY in Q1 2026. This powerful uptrend, coupled with a beta of 0.88, suggests the move is fundamentally driven rather than speculative.
- Strong & Fortified Balance Sheet: The company exhibits minimal financial risk with a low debt-to-equity ratio of 0.12 and a healthy current ratio of 1.58. It generates robust free cash flow of $76.28M TTM, funding growth internally and providing a buffer against market downturns.
- Valuation Not at Historical Peak: Despite the massive price run-up, the trailing P/E of 22.41x remains below its own recent peak of 28.67x from Q1 2025. This suggests room for multiple expansion if the company meets or exceeds its growth expectations, which are implied by a forward P/E of 27.43x.
- Dominant Position in High-Growth APAC Market: The Asia Pacific segment is the primary growth engine, contributing $611.7M or 57% of total revenue in the latest quarter. This strategic focus and strength in a key region underpin the company's accelerating top-line performance.
Bearish
- Extreme Technical Overextension Risk: The stock trades at $258.43, which is 94% of the distance between its 52-week low ($115.35) and high ($275.83). This positioning near the top of its range, after a 94.75% annual gain, indicates high susceptibility to a significant technical pullback or consolidation.
- Thin Gross Margins Pressuring Profitability: Gross margins are relatively thin at 9.92% (Q1 2026) and 10.08% historically, which is typical for contract manufacturing but leaves little room for error. This makes the business highly sensitive to input cost inflation and competitive pricing pressure.
- Limited Analyst Coverage & Divergent Views: Analyst data is sparse, with only one firm providing explicit EPS estimates, and institutional ratings show a mix of 'Buy' and 'Hold'. The wide forward EPS range ($9.56 to $10.16) signals uncertainty about the sustainability of the current earnings trajectory.
- Forward P/E Expansion Demands Perfect Execution: The forward P/E of 27.43x is higher than the trailing P/E of 22.41x, indicating the market has priced in significant future earnings growth. Any deceleration in revenue growth or margin compression would likely trigger a sharp de-rating.
PLXS Technical Analysis
The stock is in a powerful, sustained uptrend, having gained 94.75% over the past year. With a current price of $258.43, it is trading near the top of its 52-week range, positioned at approximately 94% of the distance between its 52-week low of $115.35 and high of $275.83, indicating strong momentum but also potential for near-term consolidation or overextension. Recent momentum remains robust but shows signs of deceleration; the stock is up 28.39% over three months and 17.21% over one month, suggesting the explosive gains from earlier in the year are moderating, though the trend remains firmly positive. Key technical support is anchored at the 52-week low area near $115, while immediate resistance is at the recent high near $275.83; a decisive breakout above this level would signal a continuation of the bull trend, while a breakdown below the recent consolidation range near $250 could indicate a deeper pullback. The stock's beta of 0.88 indicates it is slightly less volatile than the broader market, which is notable given its significant price appreciation, suggesting the moves are driven by fundamental improvements rather than speculative frenzy.
Beta
0.88
0.88x market volatility
Max Drawdown
-15.5%
Largest decline past year
52-Week Range
$115-$276
Price range past year
Annual Return
+88.1%
Cumulative gain past year
| Period | PLXS Return | S&P 500 |
|---|---|---|
| 1m | +9.4% | +3.3% |
| 3m | +26.8% | +6.9% |
| 6m | +88.4% | +12.4% |
| 1y | +88.1% | +23.4% |
| ytd | +64.2% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PLXS Fundamental Analysis
Revenue growth is healthy and accelerating, with the most recent quarterly revenue of $1.07 billion representing a 9.6% year-over-year increase, building on a trend of sequential quarterly revenue growth from $980 million in Q2 2025 to over $1.06 billion in Q1 2026. The Asia Pacific segment is the primary growth driver, contributing $611.7 million or approximately 57% of total revenue in the latest period, underscoring the company's strategic focus and strength in that region. Profitability is solid and margins are stable, with net income of $41.18 million and a gross margin of 9.92% in Q1 2026, compared to a net margin of 4.29% and gross margin of 10.08% from the valuation data, indicating the company maintains consistent, albeit relatively thin, operating efficiency typical for the contract manufacturing industry. The balance sheet is exceptionally strong with low financial risk, evidenced by a low debt-to-equity ratio of 0.12 and a healthy current ratio of 1.58, while the company generates substantial cash, with trailing twelve-month free cash flow of $76.28 million and a return on equity of 11.89%, demonstrating an ability to fund operations and growth internally without over-reliance on leverage.
Quarterly Revenue
$1.1B
2026-01
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.09%
Latest Quarter
Free Cash Flow
$76282000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PLXS Overvalued?
Given a positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 22.41x and a forward PE of 27.43x; the higher forward multiple suggests the market is pricing in expectations for continued earnings growth in the coming year. Compared to sector averages, specific industry comparison data is not available in the provided dataset, preventing a quantified peer comparison; however, a trailing PE in the low-20s for a company with nearly 95% annual price appreciation and accelerating revenue growth could be viewed as reasonable if the growth trajectory is sustainable. Historically, the current trailing PE of 22.41x sits below its own recent peak of 28.67x from Q1 2025, indicating the stock is not at its most expensive historical level despite the massive price run-up, which may leave room for multiple expansion if growth expectations are met or exceeded.
PE
22.4x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~43x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: PLXS's primary financial risk is not leverage but margin pressure. With gross margins consistently around 10%, the business operates on thin ice, where minor cost overruns or pricing concessions can disproportionately impact the bottom line. The net margin of 4.29% offers limited cushion. Furthermore, while the Asia Pacific segment drives 57% of revenue, this geographic concentration exposes the company to regional economic, political, or supply chain disruptions that could abruptly halt growth.
Market & Competitive Risks: The paramount market risk is valuation compression. Trading at a forward P/E of 27.4x, the stock embeds high growth expectations. If quarterly revenue growth decelerates from the current 9.6% pace or if sector-wide multiple compression occurs, the stock's premium could rapidly unwind. Competitive risks are inherent in contract manufacturing, where clients may shift production based on cost, potentially pressuring PLXS's already thin margins. The stock's beta of 0.88 suggests it is not a safe haven and will correlate with broader market downturns.
Worst-Case Scenario: The worst-case scenario involves a simultaneous earnings miss and a broader market sell-off triggering a severe de-rating. If revenue growth halts and margins contract, the forward P/E could compress towards its 52-week low valuation implied by a price of $115.35. This chain of events could see the stock decline approximately -55% from its current price of $258.43 to retest the 52-week low, representing a realistic, though severe, downside scenario for investors entering at these elevated levels.